Maqola

Study of Cardiovascular Risk Prediction in Patients with Type 2 Diabetes with Arterial Hypertension after Combined Hypotensive Therapy of Enalapril with Moxonidine

Z. A. ErgashevaSenior lecturer, Department of Pharmacology and Clinical Pharmacology, Andijan State Medical Institute, Andijan, Uzbekistan;Bustanov SherzodbekHead of the Department of 2nd-Preparation of General Practitioners, Andijan State Medical Institute, Andijan, Uzbekistan;Bakhtiyorjon JurabaevPhD, Docent,Mamurjon TurgunovDepartment of 2nd-Preparation of General Practitioners, Andijan State Medical Institute, Andijan, Uzbekistan;Mukhayyo AkhmatokhunovaHead of the Department of 2nd-Preparation of General Practitioners, Andijan State Medical Insti-tute, Andijan, Uzbekistan

International Journal of Current Research and Reviewjournal2020en

ABI

Annotatsiya

Treatment of arterial hypertension in type 2 diabetes mellitus patients is complex and at the same time, according to our data, possible and/or controlled process. For example, the use of combined antihypertensive therapy of enalapril with moxonidine is effective in the treatment of arterial hypertension in patients with type 2 diabetes, which has a positive effect on the dynamics of catecholamine excretion and 3,4-dioxyphenylalanine, monoamine oxidase activity, significantly reduces the level of Malone dialdehyde in serum.

Mavzular

Analytical Methods in Pharmaceuticals Blood Pressure and Hypertension Studies

Identifikatorlar

DOI: 10.31782/ijcrr.2020.121623

Iqtiboslar va manbalar

0 ta iqtibos21 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar · Tez orada